SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950123-08-005789
Filing Date
2008-05-16
Accepted
2008-05-16 12:55:11
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 y58693sv3.htm S-3 327993
2 EX-4.3: FORM OF INDENTURE FOR SENIOR DEBT SECURITIES y58693exv4w3.htm EX-4.3 371163
3 EX-4.4: FORM OF INDENTURE FOR SUBORDINATED DEBT SECURITIES y58693exv4w4.htm EX-4.4 390293
4 EX-5.1: OPINION OF REED SMITH LLP y58693exv5w1.htm EX-5.1 25932
5 EX-12.1: STATEMENT REGARDING COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES y58693exv12w1.htm EX-12.1 15534
6 EX-23.1: CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM y58693exv23w1.htm EX-23.1 2091
7 EX-23.2: CONSENT OF REED SMITH LLP y58693exv23w2.htm EX-23.2 3434
  Complete submission text file 0000950123-08-005789.txt   1137877
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

IRS No.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-150965 | Film No.: 08841272
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1